Central Nervous System: Clinical Trials

1 trial for Central Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Central Nervous System: new trials by email Literature Review of Central Nervous System trials Research Report on Central Nervous System

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
Alectinib - Neoplasms, Colorectal Neoplasms
Phase 2TerminatedHoffmann-La Roche12021-05-242023-08-07

Narrower conditions

Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Renal Cell (1)  ·  Cholangiocarcinoma (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)

Broader conditions

Adenocarcinoma (1)  ·  Adenocarcinoma, Papillary (1)  ·  Adnexal Diseases (1)  ·  Brain Diseases (1)  ·  Breast Diseases (1)  ·  Bronchial Diseases (1)  ·  Carcinoma (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)

Interventions

alectinib (1)

Sponsors

Hoffmann-La Roche (1)

Countries

United States (1)